- Issuer ticker
-
BVS
- Reported as of
-
14 Mar 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
17 Mar 2026, 17:03:39 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Anthony D'Adamio, Attorney-in-Fact
Key filing fact
Mark Leonard Singleton filed Form 4 for Bioventus Inc. (BVS) on 17 Mar 2026.
Key facts
- This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
- 7 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 17 Mar 2026, 17:03.
Change
- Previous filing in this sequence was filed on 20 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001914936
Primary reporting owner
Singleton Mark Leonard
- Relationship
-
SVP & CFO
- Address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
- Signature
- /s/ Anthony D'Adamio, Attorney-in-Fact
- Signature date
- 17 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BVS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +13,500
- Change %
- +8.9%
- Price
-
$0.000000*
- Shares after
- 165,312
- Date
- 13 Mar 2026
- Ownership
- Direct
BVS
transaction
Class A Common Stock
Tax liability
- Transaction value
- Shares
- -5,865
- Change %
- -3.5%
- Price
-
$8.62*
- Shares after
- 159,447
- Date
- 13 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BVS
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +54,000
- Change %
- Price
-
$0.000000*
- Shares after
- 54,000
- Date
- 14 Mar 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 54,000
- Exercise price
- Footnotes
- F1, F2
BVS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +61,000
- Change %
- Price
-
$0.000000*
- Shares after
- 61,000
- Date
- 14 Mar 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 61,000
- Exercise price
- $9.61
- Footnotes
- F2
BVS
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +104,000
- Change %
- Price
-
$0.000000*
- Shares after
- 104,000
- Date
- 13 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 104,000
- Exercise price
- Footnotes
- F1, F3
BVS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +116,000
- Change %
- Price
-
$0.000000*
- Shares after
- 116,000
- Date
- 13 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 116,000
- Exercise price
- $8.62
- Footnotes
- F3
BVS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -13,500
- Change %
- -25%
- Price
-
$0.000000*
- Shares after
- 40,500
- Date
- 13 Mar 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 13,500
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes